Empfehlungen zur Diagnostik des Bronchialkarzinoms

Das Bronchialkarzinom ist mit weitem Abstand die häufigste Krebserkrankung des Mannes, während es bei der Frau in der Häufigkeit die dritte Stelle nach dem Mammakarzinom und nach dem Kolonkarzinom einnimmt. Bei einer geschätzten Inzidenz von 71/100 000 für Männer und 20/100 000 für Frauen sind 1996 in Deutschland ca. 37 000 Menschen am Bronchialkarzinom verstorben [[1]]. Während die Inzidenz bei Männern seit 1980 unverändert ist, hat sie sich bei Frauen in diesem Zeitraum nahezu verdoppelt. Die Inzidenz- und Mortalitätsmuster reflektieren mit einer Latenz von 20 Jahren den inhalativen Tabakkonsum in der Bevölkerung. Weiterhin sind Asbest, Arsen, Nickel, polyzyklische Kohlenwasserstoffe, Chromate und ionisierende Strahlung ätiologisch relevante Karzinogene.

Literatur

• 1 Statistisches Jahrbuch für die Bundesrepublik Deutschland .Stuttgart: Metzler-Poeschel 1998
• 2 Fontana R S, Sanderson D R, Taylor W F, Woolner L B, Miller W E, Muhm J R, Uhlenhopp M A. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study.  Am Rev Respir Dis. 1984;  130 561-565
• 3 Frost J K, Ball Jr W C, Levin M L, Tockman M S, Baker R R, Carter D, Egglestone J C, Erozan Y S, Gupta P K, Khouri N F. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study.  Am Rev Respir Dis. 1984;  130 549-554
• 4 Kubik A, Parkin D M, Khlat M, Erban J, Polak J, Adamec M. Lack of benefit from semi-annual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia.  Int J Cancer. 1990;  45 26-33
• 5 Martini N. Results of Memorial Sloan-Kettering lung project.  Recent Results Cancer Res. 1982;  82 174-178
• 6 Flehinger B, Kimmel M, Polyak T, Melamed M. Screening for lung cancer.  Cancer. 1993;  72 1573-1580
• 7 Strauss G M, Gleason R E, Sugarbaker D J. Screening for lung cancer. Another look; a different view.  Chest. 1997;  111 754-768
• 8 Mulshine J L, Scott F. Molecular markers in early cancer detection. New screening tools.  Chest. 1995;  107 (6 suppl) 280-286
• 9 Tockman M S, Erozan Y S, Gupta P, Piantadosi S, Mulshine J L, Ruckdeschel J C. The early detection of second primary lung cancer by sputum immunostaining. LCEWDG investigators: Lung Cancer Early Detection Group.  Chest. 1994;  106 385-390
• 10 Baumgartner R, Huber R M, Schulz H, Stepp H, Rick K, Gamarra F, Leberig A, Roth C. Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer.  J Photochem Photobiol. 1996;  B 36 169-174
• 11 Lam S, Kennedy T, Unger M, Miller Y E, Gelmont D, Rusch V, Gipe B, Howard D, LeRiche J C, Coldman A, Gazdar A F. Localization of bronchial epithelial neoplastic lesions by fluorescence bronchoscopy.  Chest. 1998;  113 696-702
• 12 Khanavkar B, Gnudi F, Muti A, Marek W, Müller K M, Atay Z, Topalidis T, Nakhosteen J A. Grundlagen der LIFE-Autofluoreszenzbronchoskopie. Ergebnisse nach 194 Untersuchungen im Vergleich mit Standardverfahren der Früherkennung des Bronchialkarzinoms - Übersicht.  Penumologie. 1998;  52 71-76
• 13 Andersen H A, Prakash U BS. Diagnosis of symptomatic lung cancer.  Semin Respir Med. 1982;  3 165-175
• 14 Cohen M H. Signs and symptoms of bronchogenic carcinoma. In: Strauss MJ (Hrsg): Lung Cancer, Clinical Diagnosis and Treatment. 2nd Ed. New York: Grune and Stratton 1983: 97-111
• 15 Cromartie R S, Park E F, May J E. et al . Carcinoma of the lung: a clinical review.  Ann Thorac Surg. 1980;  30 30-35
• 16 Grippi M A. Clinical aspects of lung cancer.  Semin Roentgenol. 1990;  25 12-24
• 17 Nathanson L, Hall T C. Paraneoplastic Syndromes.  Semin Oncol. 1997;  24,3 265-381
• 18 Ferrigno D, Buccheri G. Clinical applications of serum markers for lung cancer.  Respir Med. 1995;  89 587-597
• 19 Spiro S G. Bronchial tumors. In: Brewis RAL, Corrin B, Geddes DM, Gibson GJ (Hrsg): Respiratory Medicine New York: WB Saunders 1995
• 20 World Health Organization .Histological Typing of Lung and Pleural Tumors, 3nd ed. Geneva: World Health Organization 1999
• 21 Roggli V L, Vollmer R T, Greenberg S D, McGavran M H, Spjut H J, Yesner R. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases.  Hum Pathol. 1985;  16 569
• 22 Thomas J S, Lamb D, Ashcroft T, Corrin B, Edwards C W, Gibbs A R, Kenyon W E, Stephens R J, Whimster W F. How reliable is the diagnosis of lung cancer using small biopsy specimens? Reports of a UKCCCR Lung Cancer Working Party.  Thorax. 1993;  48 1135-1139
• 23 Leitlinien der Bundesärztekammer zur Qualitätssicherung in der Röntgendiagnostik . Qualitätskriterien röntgenologische Untersuchungen.  Dtsch Ärzteblatt. 1995;  92 A 2272-2285
• 24 Bittner R C, Felix R. Magnetic resonance (MR) imaging of the chest: state-of-the-art.  Europ Resp J. 1998;  11 1392-1404
• 25 Ratto G B, Piancenza G, Frola C, Musante F, Serrano R, Giua R, Salio M, Jacovoni P, Rovida S. Chest wall involvement by lung cancer: computed tomographic detection and results of operation.  Ann Thorac Surg. 1991;  51 182-188
• 26 Padovani B, Mouroux J, Seksik L, Chanalet S, Sedat J, Rotomondo C, Richelme H, Serres J. Chest wall invasion by bronchogenic carcinoma: evaluation with MR-imaging.  Radiology. 1993;  187 33-38
• 27 Martini N, Heelan R, Westcott J, Bains M, McCormack P, Caravelli J, Watson R, Zaman M. Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma.  J Thorac Cardiovasc Surg. 1985;  90 639-648
• 28 Laurent F, Drouillard J, Dorcier F, Velly J, Barat J, Grelet P, Martigne C, Tavernier J, Couraud L. Bronchogenic carcinoma staging: CT versus MR imaging. Assessment with surgery.  Eur J Cardiothorac Surg. 1988;  2 31-36
• 29 Bülzebruck H, Bopp R, Drings P, Bauer E, Krysa S, Probst G, van Kaick G, Müller K M, Voigt-Moykopf I. New aspects in the staging of lung cancer. Prospective validation of the international Union Against Cancer TNM-classification.  Cancer. 1992;  70 1102-1110
• 30 Glazer H S, Duncan-Meyer J, Aronberg D J, Moran J F, Levitt R G, Sagel S S. Pleural and chest wall invasion in bronchogenic carcinoma: CT evaluation.  Radiology. 1985;  157 191-194
• 31 American Thoracic Society/European Respiratory Society . Pretreatment evaluation of non-small-cell lung cancer.  Am J Respir Crit Care Med. 1997;  156 320-332
• 32 Castagno A A, Shuman W P. MR imaging in clinically suspected brachial plexus tumor.  AJR. 1987;  149 1219-1222
• 33 Rapoport S, Blair D N, McCarthy S M, Desser T S, Hammers L W, Sostman H D. Brachial plexus: correlation of MR imaging with CT and pathologic findings.  Radiology. 1988;  167 161-165
• 34 Libshitz H I, McKenna Jr R J, Mountain C F. Mediastinal lymph node size in lung cancer.  AJR. 1984;  143 715-718
• 35 Platt J F, Glazer G M, Orringer M B, Gross B H, Quint L E, Francis I R, Bland P H. Radiologic evaluation of the subcarinal lymph nodes: a comparative study.  AJR. 1988;  151 279-282
• 36 Friedman P J, Feigin D S, Liston S E, Alazraki N P, Haghighi P, Young J A, Peters R M. Sensitivity of chest radiography, computed tomography, and gallium scanning to metastasis of lung carcinoma.  Cancer. 1984;  54 1300-1306
• 37 Frederick H M, Bernhardino M E, Baron M, Colvin R, Mansour K, Miller J. Accuracy of chest computerized tomography in detecting malignant hilar and mediastinal involvement by squamous cell carcinoma of the lung.  Cancer. 1984;  54 2390-2395
• 38 Staples C A, Müller N L, Miller R R, Evans K G, Nelems B. Mediastinal nodes in bronchogenic carcinoma: comparison between CT and mediastinoscopy.  Radiology. 1988;  167 367-372
• 39 McLoud T C, Bourgouin P M, Greenberg R W, Kosiuk J P, Templeton P A, Shepard J AO, Moore E H, Wain J C, Mathisen D J, Grillo H C. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling.  Radiology. 1992;  182 319-323
• 40 McKenna R J, Libshitz H I, Moutain C F. Roentgenographic evaluation of mediastinal nodes for preoperative assessment in lung cancer.  Chest. 1985;  88 206
• 41 Gross B H, Glazer G M, Orringer M B, Spizarny D L, Flint A. Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance.  Radiology. 1988;  166 71-74
• 42 The Canadian Lung Oncology Group . Investigation for mediastinal desease in patients with apparently operable lung cancer.  Ann Thorac Surg. 1995;  60 1382-1389
• 43 Silvestri G A. Staging strategies for patients with newly diagnosed bronchogenic carcinoma: the importance of the clinical evaluation.  Sem Resp Crit Care Med. 1996;  17 343-348
• 44 Hillers T K, Sauve M D, Guyatt G H. Analysis of published studies on the detection of extrathoracic metastases in patients presumed to have operable non-small cell lung cancer.  Thorax. 1994;  49 14-19
• 45 Salvatierra A, Baamonde C, Ilamas J M, Cruz F, Lopez-Pujol J. Extrathoracic staging of bronchogenic carcinoma.  Chest. 1990;  97 1052-1058
• 46 Colice G, Birkmeyer J, Black W, Littenberg B, Silvestri G. Cost-effectiveness of head CT in patients with lung cancer and no clinical evidence of metastases.  Chest. 1995;  108 1264-1721
• 47 Michel F, Soler M, Imhof E, Perruchoud A P. Initial staging of non-small cell lung cancer: value of routine radioisotope bone scanning.  Thorax. 1991;  46 469-473
• 48 Silvestri G A, Littenberg B, Colice G L. The clinical evaluation for detecting metastatic lung cancer: a meta-analysis.  Am J Respir Crit Care Med. 1995;  152 225-230
• 49 Moser E. Skelett-, Knochenmarkszintigraphie oder spezifische Verfahren.  KrankenhausArzt. 1997;  70 435-439
• 50 Reske S N, Bares R, Büll U, Guhlmann A, Moser E, Wannenmacher M F. Klinische Wertigkeit der Positronen-Emissions-Tomographie (PET) bei onkologischen Fragestellungen: Ergebnisse einer interdisziplinären Konsensus-Konferenz.  Nuklear Medizin. 1996;  35 42-52
• 51 Frank A, Lefkowitz D, Jaeger S, Gobar L, Sunderland J, Gupta N, Scott W, Mailliard J, Lynch W, Bishop J. et al . Decision logic for retreatment of asymptomatic lung cancer recurrence based on positron emission tomography findings.  Int J Radiat Oncol Biol Phys. 1995;  32 1495-1512
• 52 Gould M K, Owens D K. Positron emission tomography for mediastinal staging in non-small cell lunger cancer: A meta-analysis.  Am J Respir Crit Care Med. 1998;  157 A256
• 53 Hughes J MB. ¹⁸F-Fluorodeoxyglucose PET scans in lung cancer.  Thorax. 1996;  51 (Suppl 2) 16-22
• 54 Inoue T, Kim E E, Komaki R, Wong F C, Bassa P, Wong W H, Yang D J, Endo K, Podoloff D A. Detecting recurrent or residual lung cancer with FDG-PET.  J Nucl Med. 1995;  36 788-793
• 55 Vansteenkiste J F, Stroobands S G, DeLeyn P R, Dupont P J, Bogaert J, Mases A H, Deneffe G J, Nackaerts K L, Verschakelen J A, Lerut T E, Mortelsmans L A, Demendts M G. Lymph node staging in non-small cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.  J Clin Oncol. 1998;  16 2142-2149
• 56 Stokkel M P, Kwa B M, Pauwels E K. Imaging and staging of small-cell lung cancer: is there a future role for octreotide scintigraphy.  Br J Clin Pract. 1995;  49 235-238
• 57 Valkema R, Steens J, Cleton F J, Pauwels E KJ. The diagnostic utility of somatostatin receptor scintigraphy in oncology.  J Cancer Res Clin Oncol. 1996;  122 513-532
• 58 Rudd R M, Gellert A R, Boldy D A, Studdy P R, Pearson M C, Geddes D M, Sinha G. Bronchoscopic and percutaneous aspiration biopsy in the diagnosis of bronchial carcinoma cell type.  Thorax. 1982;  37 462-465
• 59 Dvale P A, Bode F R, Kini S. Diagnostic accuracy in lung cancer. Comparison of techniques used in association with flexible fiberoptic bronchoscopy.  Chest. 1976;  69 752-757
• 60 Richardson R H, Zavala D C, Jukerkee P K. The use of fiberoptic bronchoscopy and brush biopsy in the diagnosis of suspected pulmonary malignancy.  Am Rev Respir Dis. 1974;  109 63-66
• 61 Schaberg T, Mai J, Thalmann U, Loddenkemper R. Die transbronchiale Lymphknotenpunktion über das Fiberbronchoskop bei pulmonalen Neoplasmen.  Prax Klin Pneumol. 1986;  40 306-311
• 62 Dierkesmann R. The diagnostic yield of bronchoscopy.  Cardiovasc Intervent Radiol. 1991;  14 24-28
• 63 Loddenkemper R, Schaberg T, Mai J, Preussler H, Brandt H J. Bronchial evaluation of peripheral localised lung lesions: accuracy of different biopsy techniques.  Eur J Respir Dis. 1983;  64 (suppl) 461-464
• 64 Arroliga A C, Matthay R A. The role of bronchoscopy in lung cancer.  Clin Chest Med. 1993;  14 87-98
• 65 Schönfeld N, Loddenkemper R. Pleural biopsy and thoracoscopy.  Eur Respir Mon. 1998;  9 135-152
• 66 Loddenkemper R. Thoracoscopy - state of the art.  Eur Respir J. 1998;  11 213-221
• 67 Kaiser D, Ennker I C, Hartz C. Video-assisted thoracoscopic surgery - indications, results, complications, and contraindications.  Thorac Cardiovasc Surg. 1993;  41 330-334
• 68 Westcott J L. Percutaneous transthoracic needle biopsy.  Radiology. 1988;  169 593-601
• 69 Jereb M. The usefulness of needle biopsy in chest lesions of different sizes and locations.  Radiology. 1980;  134 13-15
• 70 Seyfer A E, Walsh D S, Graeber G M, Nuno I N, Eliasson A H. Chest wall implantation of lung cancer after thin needle aspiration biopsy.  Ann Thorac Surg. 1989;  48 284-286
• 71 Hix W R, Aaron B L. Needle aspiration in lung cancer. Risk of tumor implantation.  Chest. 1990;  96 1539-1540
• 72 Luke W, Pearson F, Todd T, Patterson G, Cooper J. Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung.  J Thoracic Cardiovasc Surg. 1986;  91 53-56
• 73 Deutsche Gesellschaft für Pneumologie und Deutsche Gesellschft für Thorax-, Herz- und Gefäßchirurgie . Empfehlungen zur Diagnostic, Stadieneinteilung und operativen Therapie des Bronchialkarzinoms.  Pneumologie. 1994a;  48 262-269
• 74 Kaiser D. Operative Therapie. In: Loddenkemper R (Hrsg): Das Bronchialkarzinom und andere bronchopulmonale Tumoren Stuttgart: Kohlhammer 1998: 94-131
• 75 Choi N C, Carey R W, Daly W, Mathisen D, Wain J, Wright C, Lynch T, Grossbard M, Grillo H. Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small-cell lung cancer.  J Clin Oncol. 1997;  15 712-722
• 76 Eberhardt W, Wilke H, Stamatis G, Stuschke M, Harstrick A, Menker H, Krause B, Müller M R, Stahl M, Flasshove M, Budach V, Greschuchna D, Konietzko N, Sack H, Seeber S. Preoperative chemotherapy followed by concurrent chemoradiation therapy based on hyperfractionated accelerated radiotherapy and definitive surgery in locally advanced non-small-cell lung cancer: mature results of a phase II trial.  J Clin Oncol. 1998;  16 622-634
• 77 Thomas M, Rübe C, Semik M, von Eiff M, Freitag L, Macha H N, Wagner W, Klinke F, Scheld H H, Willich N, Berdel W E, Junker K. Impact of preoperative bimodality induction including twice-daily radiation on tumor regression and survival in stage III non-small cell lung cancer.  J Clin Oncol. 1999;  17 1185-1193
• 78 Kondo D, Imaizumi M, Abe T, Naruke T, Suemasu K. Endoscopic ultrasound examination for mediastinal lymph node metastases of lung cancer.  Chest. 1990;  98 586-593
• 79 Armstrong P, Reznek R H, Philips R R. Diagnostic imaging of lung cancer.  Eur Respir Mon. 1995;  1; 1 137-187
• 80 Chang K J, Erickson R A, Nguyen P. Endoscopic ultrasound (EUS) and EUS-guided fine needle aspiration of the left adrenal gland.  Gastrointest Endosc. 1996;  44 568-572
• 81 Becker H D, Messerschmidt E, Schindelbeck F, Ott S. Endobronchialer Ultraschall.  Pneumologie. 1997;  51 620-629
• 82 Quanjer P H, Tammeling G J, Cotes J E, Pederson O F, Peslin R, Yernault O F. Standardized lung function testing: lung volumes and forced expiratory flows. 1993 update.  Eur Respir J. 1993;  6 4-40
• 83 Bolliger C T, Perruchoud A P. Functional evaluation of the lung resection candidate.  Eur Respir J. 1998;  11 198-212
• 84 Crapo R O. Carbon monoxide diffusing capactiy (transfer factor).  Semin Respir Crit Care Med. 1998;  19 335-347
• 85 Deutsche Gesellschaft für Pneumologie . Empfehlungen zur Durchführung und Bewertung von Belastungsuntersuchungen in der Pneumologie.  Pneumologie. 1998;  52 225-232
• 86 Wassermann K, Whipp B. Exercise physiology in health and disease.  Am Rev Respir Dis. 1975;  112 219-249
• 87 Schulz C, Emslander H, Riedel M. Beurteilung der funktionellen Operabilität von Patienten mit Bronchialkarzinom.  Pneumologie. 1999;  53 337-347
• 88 Alberts W M. Pulmonary complications of cancer treatment.  Current Opinion in Oncology. 1997;  9 161-169
• 89 Bolliger C T, Wyser C, Roser H, Stulz P, Solèr M, Perruchoud A P. Lung scanning and exercise testing for the prediction of postoperative performance in lung resection candidates at increased risk for complications.  Chest. 1995;  108 341-348
• 90 Deutsche Gesellschaft für Pneumologie . Empfehlungen zur präoperativen Lungenfunktionsdiagnostik.  Pneumologie. 1994;  48 296-299
• 91 Bolliger C T, Jordan P, Solèr M, Stulz P, Gradel E, Skarvan S, Elsasser S, Gonon M, Wyser C, Tamm M, Perruchoud A P. Exercise capacity as a predictor of postoperative complications in lung resection candidates.  Am J Respir Crit Care Med. 1995b;  151 1472-1480
• 92 Mountain C. Revisions in the international system for staging lung cancer.  Chest. 1997;  111 1710-1717
• 93 Mountain C, Dresler C. Regional lymphnode classification for lung cancer staging.  Chest. 1997;  111 1718-1723
• 94 Pearson F, De Larue N, Ilves R, Todd T, Cooper J. Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung.  J Thorac Cardiovasc Surg. 1982;  83 1-11
• 95 Martini N, Flehinger B. The role of surgery in N2 lung cancer.  Surg Clin North Am. 1987;  7 1037-1049
• 96 Graziano S. Non-small-cell lung cancer: Clinical value of new biological predictors.  Lung Cancer. 1997;  17 (Suppl 1) S37-S58
• 97 Thomas M. Tumorassoziierte Prognoseparameter beim nicht-kleinzelligen Bronchialkarzinom.  Pneumologie. 1997;  51 669-677
• 98 Thomas M, Rübe C, Semik M, von Eiff M, Klinke F, Macha H N, Freitag L, Scheld H H, Willich N, Berdel W E, Junker K. Trimodality therapy in stage III non-small-cell lung cancer: prediction of recurrence by assessment of p185^neu .  Eur Respir J. 1999;  13 424-429